4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000899243-22-002881
Options or other derivatives
- VP Finance & Accounting acquired 40,000 shares (grant or award)
From the SEC's structured data for this filing
Fulcrum Therapeutics, Inc. Filed Acc 0000899243-22-002881
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…